Episode 17: Chillin’ in France with TTM
Should we chill out with the non-shockable cardiac arrests? Another look at targeted temperature management. First, we knew early hypothermia after ROSC saved brains. Then, we learned that doing it in the field didn’t make a difference and that there was no difference between 33C and 36C. This month, the NEJM published the HYPERION trial of non-shockable arrests randomized to hypothermia (33C) or normothermia (37C). If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe (or download each episode several times… we’ve gotta beat SecondShift after all).
